Borderline personality disorder
Conditions
Interventions
None listed
Sponsors
Nippon Boehringer Ingelheim Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Physicians and psychologists who have been taking care of patients or clients (with or without notification) diagnosed with BoPD using DSM-5 or other BoPD diagnosis criteria for at least a month
Exclusion criteria
Exclusion criteria: Steering committee members and advisors for this study, and physicians and psychologists affiliated with NBI, Mebix and Qlife
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1)Background of study subjects (2)Number of BoPD patients (or clients), experiences and rate of outpatients (3)Background, diagnosis and treatment for BoPD patients or clients | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Feasibility of next future studies | — |
Countries
Japan
Contacts
Public ContactTomoyoshi Kaneko
Mebix, Inc. Division of research promotion
Outcome results
None listed